Net Margin - Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) - Alpha Spread

Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705

Watchlist Manager
Hunan Jiudian Pharmaceutical Co Ltd Logo
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
Watchlist
Price: 24.63 CNY 13.45% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Hunan Jiudian Pharmaceutical Co Ltd?
Write Note

Net Margin
Hunan Jiudian Pharmaceutical Co Ltd

16%
Current
13%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16%
=
Net Income
454.8m
/
Revenue
2.8B

Net Margin Across Competitors

Country CN
Market Cap 12B CNY
Net Margin
16%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 843.2B USD
Net Margin
19%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.5T DKK
Net Margin
35%
Country US
Market Cap 385.8B USD
Net Margin
44%
Country US
Market Cap 278.3B USD
Net Margin
22%
Country UK
Market Cap 240.2B USD
Net Margin
13%
Country CH
Market Cap 206.2B CHF
Net Margin
20%
Country CH
Market Cap 191.4B CHF
Net Margin
33%
Country US
Market Cap 162B USD
Net Margin
-5%

Profitability Report

View the profitability report to see the full profitability analysis for Hunan Jiudian Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16%
=
Net Income
454.8m
/
Revenue
2.8B
What is the Net Margin of Hunan Jiudian Pharmaceutical Co Ltd?

Based on Hunan Jiudian Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 16%.